co.don chondrosphere, 10-70 sphäroide/cm^2 matrixassoziierte zellen zur implantation
co.don gmbh (1011513) - sphäroide aus humanen autologen matrixassoziierten chondrozyten - suspension zur implantation - teil 1 - transplantat humanen ursprungs; sphäroide aus humanen autologen matrixassoziierten chondrozyten (38505) zellen (biologische)
alsoft
saraya co. ltd. europe (8109305) - 2-propanol (ph.eur.); 1-propanol (ph.eur.) - lösung zur anwendung auf der haut - teil 1 - lösung zur anwendung auf der haut; 2-propanol (ph.eur.) (00820) 63,14 gramm; 1-propanol (ph.eur.) (03244) 14,3 gramm
co-perindocor 2mg/0,625mg tabletten
easypharm gmbh & co kg - indapamid; perindopril-tert-butylamin -
co-perindocor 4mg/1,25mg tabletten
easypharm gmbh & co kg - indapamid; perindopril-tert-butylamin -
co-dorzolamid-mepha 2% / 0.5%.augentropfen co-dorzolamid-mepha 2% / 0.5%.augentropfen
mepha pharma ag - dorzolamidum, timololum - co-dorzolamid-mepha 2% / 0.5%.augentropfen - dorzolamidum 20 mg zu dorzolamidi hydrochloridum, timololum 5 mg zu timololi maleas, conserv.: benzalkonii chloridum, aqua ad iniectabilia q.s. zu einer lösung anstelle von 1 ml. - glaukom - synthetika
co-telmisartan spirig hc 80/25 mg tabletten co-telmisartan spirig hc 80/25 mg tabletten
spirig healthcare ag - telmisartanum, hydrochlorothiazidum - co-telmisartan spirig hc 80/25 mg tabletten - telmisartanum 80 mg, hydrochlorothiazidum 25 mg, magnesii stearas, kalii hydroxidum corresp. kalium 6.37 mg, megluminum, povidonum k 29-32, carboxymethylamylum natricum a corresp. natrium 1.66 mg, cellulosum microcristallinum, mannitolum, pro compresso. - antihypertensivum - synthetika
vancomycin co-pharma 125 mg hartkapseln
co-pharma limited - vancomycin - hartkapseln - 125mg - intestinale antiinfektiva, antibiotika - vancomycin-kapseln sind angezeigt für die behandlung von: • antibiotikabedingter pseudomembranöser enterokolitis durch clostridium difficile • staphylokokken-enterokolitis bei anderen infektionen ist vancomycin, wenn es oral angewendet wird, nicht wirksam, da es aus dem magen-darm-trakt nicht nennenswert resorbiert wird. die offiziellen richtlinien für die richtige anwendung von antibakteriellen wirkstoffen sollten beachtet werden.
vectormune fp ilt + ae
ceva-phylaxia co. ltd. - live recombinant fowlpox virus expressing the membrane fusion protein and the encapsidation protein of avian infectious laryngotracheitis virus (rfp-lt) and avian encephalomyelitis virus, strain calnek 1143 (ae) - immunologicals for aves, live viral vaccines, domestic fowl - hähnchen - for active immunisation of chickens of 8 to 13 weeks of age in order to reduce the skin lesions due to fowlpox, to reduce the clinical signs and tracheal lesions due to avian infectious laryngotracheitis and to prevent egg production losses due to avian encephalomyelitis.
vectormune fp ilt
ceva-phylaxia co. ltd. - recombinant fowlpox virus expressing the membrane fusion protein and the encapsidation protein of avian infectious laryngotracheitis virus, live - hähnchen - for active immunisation of chickens from 8 weeks of age in order to reduce the skin lesions due to fowlpox and to reduce the clinical signs and tracheal lesions due to avian infectious laryngotracheitis.
ultifend nd ibd
ceva-phylaxia veterinary biologicals co. ltd - turkey herpes virus, strain rhvt/nd/ibd, expressing the fusion protein of newcastle disease virus and the vp2 protein of infectious bursal disease virus, live recombinant - immunologische für aves - embryonated chicken eggs; chicken - for the active immunisation of one-day-old chicks or 18-day-old chicken embryonated eggs to reduce mortality, clinical signs and lesions caused by newcastle disease virus (ndv) and to reduce virus shedding; to reduce mortality, clinical signs and bursa lesions caused by very virulent infectious bursal disease virus (ibdv); to reduce mortality, clinical signs and lesions caused by classical marek’s disease virus (mdv).